Equities research analysts at William Blair decreased their FY2026 earnings per share estimates for shares of Bristol-Myers ...

Equities research analysts at William Blair upped their FY2025 EPS estimates for shares of Modine Manufacturing in a note ...

Fintel reports that on February 7, 2025, William Blair initiated coverage of Rubrik (NYSE:RBRK) with a Market Perform ...

William Blair initiated coverage of Rubrik (RBRK) with a Market Perform rating.Maximize Your Portfolio with Data Driven Insights:Leverage the ...

William Blair initiated coverage of Mersana Therapeutics (MRSN) with an Outperform rating.Maximize Your Portfolio with Data Driven ...

Neurocrine Biosciences Q4 earnings topped forecasts, but revenue slightly missed. Analysts see Ingrezza's long-term growth ...

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...

CHICAGO (WLS) -- Portillo's beat McDonald's for best value in fast food, according to a new consumer survey from William ...

The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.

CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, ...